title: Supplemental beta-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer.
authors.affiliation: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034, USA. Susan.Mayne@Yale.Edu
authors.forename: Susan T
authors.initials: ST
authors.lastname: Mayne
authors.forename: Mary
authors.initials: M
authors.lastname: Walter
authors.forename: Brenda
authors.initials: B
authors.lastname: Cartmel
authors.forename: W Jarrard
authors.initials: WJ
authors.lastname: Goodwin
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Blumberg
mesh_terms: D000328:Adult; D000368:Aged; D016588:Anticarcinogenic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage* / Q000627:therapeutic use; D019587:Dietary Supplements; D004311:Double-Blind Method; D028441:F2-Isoprostanes / Q000652:urine*; D008401:Gas Chromatography-Mass Spectrometry; D006258:Head and Neck Neoplasms / Q000517:prevention & control* / Q000652:urine; D006801:Humans; D015227:Lipid Peroxidation; D008137:Longitudinal Studies; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D016609:Neoplasms, Second Primary / Q000517:prevention & control* / Q000652:urine; D010919:Placebos; D012907:Smoking; D019207:beta Carotene / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D016588:Anticarcinogenic Agents; D000975:Antioxidants; D028441:F2-Isoprostanes; D010919:Placebos; D019207:beta Carotene